Literature DB >> 21340569

Osteonecrosis in SLE.

M Abeles, A M Abeles, J Urman, N Rothfield.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21340569     DOI： 10.1007/s00296-011-1815-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  3 in total

1.  Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus.

Authors:  Mehmet Sayarlioglu; Nergis Yuzbasioglu; Murat Inanc; Sevil Kamali; Ayse Cefle; Ozcan Karaman; Ahmet Mesut Onat; Rustem Avan; Gozde Yildirm Cetin; Ahmet Gul; Lale Ocal; Orhan Aral
Journal:  Rheumatol Int       Date:  2010-08-15       Impact factor: 2.631

Review 2.  Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation.

Authors:  E S Weiner; M Abeles
Journal:  J Rheumatol       Date:  1989-05       Impact factor: 4.666

3.  Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy.

Authors:  M Abeles; J D Urman; N F Rothfield
Journal:  Arch Intern Med       Date:  1978-05
  3 in total
  2 in total

1.  Increased COUP-TFII Expression Mediates the Differentiation Imbalance of Bone Marrow-Derived Mesenchymal Stem Cells in Femoral Head Osteonecrosis.

Authors:  Sheng-Hao Wang; Guo-Hau Gou; Chia-Chun Wu; Hsain-Chung Shen; Leou-Chyr Lin; Ru-Yu Pan
Journal:  Biomed Res Int       Date:  2019-12-08       Impact factor: 3.411

2.  Relationship between osteonecrosis and antiphospholipid antibodies in patients with systemic lupus erythematosus: a systematic review protocol.

Authors:  Qijiao Wei; Meng Zhou; Jianwen Liu; Shengli Zhang; Fei Gao; He Lin; Zhihan Chen
Journal:  BMJ Open       Date:  2021-07-22       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.